Welcome to the Division of Hematology / Oncology at the University of Pennsylvania. Our mission is to provide expert and compassionate care to adults with cancer and blood disorders while turning great science into practical benefits for more people every day.
The Hematology/Oncology Division is a world leader in hematology and medical oncology through its unparalleled and comprehensive clinical care, with a cutting-edge portfolio of transformative clinical, translational, and basic science research. This is complemented by an innovative, top-ranked educational fellowship. Key to achieving our goals is honoring our commitment to excellence and professionalism; valuing diversity, equity, inclusion, and justice; and providing a supportive, collaborative, and high quality work environment for all.
Our division comprises over 140 faculty, 30 fellows, and a large complement of advanced practice providers and nurses who support both our inpatient and outpatient practices. Our core practices, including outpatient care and infusion centers, are located at the Hospital of the University of Pennsylvania, where our patients receive care in the beautiful, state-of-the-art Pavilion which opened in 2021, the Perelman Center for Advanced Medicine, Penn Presbyterian Medical Center, Pennsylvania Hospital, Penn Medicine Radnor, Penn Medicine Valley Forge, Chester County, and in South Jersey. We partner closely with many departments, institutes, and centers across Penn's campus, including Radiation Oncology, Surgery, Neurosurgery, Obstetrics and Gynecology, the Penn Palliative Care Program, Pathology & Laboratory Medicine, and Radiology, including the Divisions of Neuroradiology, Interventional Radiology and Nuclear Medicine, who serve as important therapeutic as well as imaging partners. We are proud of our robust and groundbreaking Cell Therapy and Transplant program, who pioneered the first human trial of chimeric antigen receptor (CAR) T cells, one of many firsts by Penn investigators. Our faculty engage in research in connection with many basic science departments at the University of Pennsylvania, including the Departments of Cancer Biology, Genetics, and Cell and Developmental Biology, among others. Penn’s Immunology programs are unparalleled, and we invite you to explore our many offerings via the Immunology Graduate Group and the Institute for Immunology. We are closely aligned with the Abramson Cancer Center, which is home to our oncology and cell therapy clinical trials enterprise, the Abramson Family Cancer Research Institute, and the Penn-CHOP Blood Center for Patient Care and Discovery. We partner with colleagues at the Leonard Davis Institute (LDI), the Center for Health Incentives and Behavioral Economics (CHIBE), Penn Medical Ethics and Health Policy, the Penn Center for Cancer Care Innovation (PC3I), the Palliative and Advanced Illness Research Center (PAIR), the Center for Clinical Epidemiology and Biostatistics (CCEB), the Institute for Translational Medicine and Therapeutics (ITMAT), and the Wistar Institute. These cross-disciplinary connections represent just a sampling of Penn’s rich environment for innovative research as well as outstanding clinical care. Penn’s unique, supportive Hematology/Oncology fellowship program is one of the best in the country, training the next generation of leaders and investigators who will change the future for patients with cancer and blood diseases.
It is an honor to serve as the Chief of Penn's Division of Hematology / Oncology. Our intelligent, innovative, pathbreaking researchers and clinicians are also people who deeply care - for our patients, for one another, and for our very special and supportive culture. I invite you to explore our website to learn more about us.
Warmly –
Alison
Alison Wakoff Loren, MD, MSCE
Chief, Division of Hematology Oncology
Director, Blood & Marrow Transplant, Cell Therapy & Transplant Program
Professor of Medicine at the Hospital of the University of Pennsylvania